Matt Hall

Director, Corporate Development And Investor Relations at Anika Therapeutics

Matt Hall has extensive experience in business development, venture capital, and board membership. Matt is currently serving as the Director of Business Development at Anika, starting in March 2022. Prior to that, Matt founded Highland Park Partners in February 2016. Matt also served as a board member for Venture Club of Indiana, Inc. and Diagnotes, Inc. Matt has experience in the healthcare industry, serving as the Interim Executive Director at OrthoWorx, Inc. from September 2021 to March 2022. Additionally, they worked as a Capital Sourcing and Financing Consultant at AcceLINX from January 2020 to March 2022. Matt served as the Managing Director of Indiana Seed Fund III at BioCrossroads from an unspecified date in 2017 until March 2022. Before that, they worked as a Vice President at The Carlyle Group (AlpInvest Partners) from March 2014 to February 2016. Matt has also served on the board of Algaeon, Inc. from December 2012 to March 2014. From December 2010 to March 2014, they worked as a Principal at Indiana Seed Fund II, a life sciences venture fund managed by BioCrossroads.

Matt Hall attended Indiana University Bloomington from 1995 to 1999. Matt studied at the College of Arts and Sciences, Kelley School of Business. However, their field of study is unknown.

Links

Previous companies

BioCrossroads logo